Evegreen1 month ago
Europe’s Regulatory Body Signals Shift To ‘Weight of Evidence’ Model For Drug Approvals—How Does It Affect Psychedelic Medicines?
The European Medicines Agency is taking steps to rethink how certain high-need medicines reach patients, with a new concept paper proposing a more flexible, evidence-based pathway...